Literature DB >> 118761

Inhibition of dihydrofolate reductases by derivatives of 2,4-diaminopyrroloquinazoline.

J J McCormack, B A Allen, K W Ledig, B L Hillcoat.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 118761     DOI： 10.1016/0006-2952(79)90066-2

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN： 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  3 in total

1.  The chemistry and pharmacology of privileged pyrroloquinazolines.

Authors:  Bo Chao; Bingbing X Li; Xiangshu Xiao
Journal:  Medchemcomm       Date:  2015-04-01       Impact factor: 3.597

2.  Antimalarial activities of new pyrrolo[3,2-f]quinazoline-1,3-diamine derivatives.

Authors:  Jian Guan; Quan Zhang; Michael O'Neil; Nicanor Obaldia; Arba Ager; Lucia Gerena; Ai J Lin
Journal:  Antimicrob Agents Chemother       Date:  2005-12       Impact factor: 5.191

3.  Discovery of a Potent Anti-tumor Agent through Regioselective Mono-N-acylation of 7H-Pyrrolo[3,2-f]quinazoline-1,3-diamine.

Authors:  Jingjin Chen; Alina Kassenbrock; Bingbing X Li; Xiangshu Xiao
Journal:  Medchemcomm       Date:  2013-09-01       Impact factor: 3.597
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.